G protein-coupled estrogen receptor 1 expression in normal myometrium, leiomyoma, and adenomyosis tissues of premenopausal women

References

• Prossnitz ER, Arterburn JB, Smith HO, et al. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol. 2008;70(1):165–190.
   PubMedGoogle Scholar
• Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol. 2011;7(12):715–726.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Sestak I, Bonanni B, et al. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet. 2013;381(9880):1827–1834.
   PubMed Web of Science ®Google Scholar
• Jongen V, Briet J, de Jong R, et al. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Gynecol Oncol. 2009;112(3):537–542.
   PubMed Web of Science ®Google Scholar
• Borahay MA, Asoglu MR, Mas A, et al. Estrogen receptors and signaling in fibroids: role in pathobiology and therapeutic implications. Reprod Sci. 2017;24(9):1235–1244.
   PubMed Web of Science ®Google Scholar
• Salama SA, Nasr AB, Dubey RK, et al. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids. J Soc Gynecol Investig. 2006;13(8):542–550.
   PubMedGoogle Scholar
• Jia M, Dahlman-Wright K, Gustafsson J-Å. Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab. 2015;29(4):557–568.
   PubMed Web of Science ®Google Scholar
• Olde B, Leeb-Lundberg LM. GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab. 2009;20(8):409–416.
   PubMed Web of Science ®Google Scholar
• Revankar CM, Cimino DF, Sklar LA, et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307(5715):1625–1630.
   PubMed Web of Science ®Google Scholar
• Borahay MA, Al-Hendy A, Kilic GS, et al. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Mol Med. 2015;21(1):242–256.
   PubMedGoogle Scholar
• Zhu CX, Xiong W, Wang ML, et al. Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer. J Int Med Res. 2018;46(2):723–731.
   PubMed Web of Science ®Google Scholar
• He YY, Cai B, Yang YX, et al. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci. 2009;100(6):1051–1061.
   PubMed Web of Science ®Google Scholar
• Carmeci C, Thompson DA, Ring HZ, et al. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics. 1997;45(3):607–617.
   PubMed Web of Science ®Google Scholar
• Thomas P, Pang Y, Filardo EJ, et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146(2):624–632.
   PubMed Web of Science ®Google Scholar
• Li JJ, Duan H, Wang S, et al. Expression pattern of G-protein-coupled estrogen receptor in myometrium of uteri with and without adenomyosis. BioMed Res Int. 2017;2017:1–6.
   Web of Science ®Google Scholar
• Byun JY, Kim SE, Choi BG, et al. Diffuse and focal adenomyosis: MR imaging findings. Radiographics. 1999;19(suppl_1):S161–S170.
   PubMedGoogle Scholar
• Hermon TL, Moore AB, Yu L, et al. Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium. Virchows Arch. 2008;453(6):557–569.
   PubMed Web of Science ®Google Scholar
• Jakimiuk AJ, Bogusiewicz M, Tarkowski R, et al. Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril. 2004;82:1244–1249.
   PubMed Web of Science ®Google Scholar
• Tian R, Wang Z, Shi Z, et al. Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle. Fertil Steril. 2013;99(1):256–263.
   PubMed Web of Science ®Google Scholar
• Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164–185.
   PubMed Web of Science ®Google Scholar
• Tanos V, Berry KE. Benign and malignant pathology of the uterus. Best Pract Res Clin Obstet Gynaecol. 2018;46:12–30.
   PubMed Web of Science ®Google Scholar
• Simões VL, Alves MG, Martins AD, et al. Regulation of apoptotic signaling pathways by 5α-dihydrotestosterone and 17β-estradiol in immature rat Sertoli cells. J Steroid Biochem Mol Biol. 2013;135:15–23.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wei F, Zhang J, et al. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway. Arch Biochem Biophys. 2017;633:29–39.
   PubMed Web of Science ®Google Scholar
• Zhu P, Liao LY, Zhao TT, et al. GPER/ERK&AKT/NF-kappaB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells. Mol Cell Endocrinol. 2017;442:68–80.
   PubMed Web of Science ®Google Scholar
• Huang GS, Gunter MJ, Arend RC, et al. Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma. Am J Obstet Gynecol. 2010;203(3):242e1–242e5.
   Web of Science ®Google Scholar
• Bologa CG, Revankar CM, Young SM, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006;2(4):207–212.
   PubMed Web of Science ®Google Scholar